{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:09:48Z","timestamp":1791727788752,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ijantimicag.2023.106933","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T12:31:02Z","timestamp":1690288262000},"page":"106933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae bacteraemia in children: a retrospective study"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-9898","authenticated-orcid":false,"given":"Haiyang","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5839-7993","authenticated-orcid":false,"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxia","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7411-1430","authenticated-orcid":false,"given":"Jingli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.106933_bib0001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11908-015-0510-9","article-title":"Carbapenem-Resistant Enterobacteriaceae Infections in Children","volume":"18","author":"Chiotos","year":"2016","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0002","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3201\/eid2111.150548","article-title":"Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012","volume":"21","author":"Logan","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0003","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/INF.0000000000000987","article-title":"Clinical Characteristics of Carbapenem-resistant Klebsiella pneumoniae Infections in Ill and Colonized Children in Colombia","volume":"35","author":"Diaz","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0004","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/mdr.2017.0031","article-title":"Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-beta-Lactamase-1","volume":"24","author":"Dong","year":"2018","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12879-018-3160-3","article-title":"Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0006","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1586\/14787210.2013.836057","article-title":"Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections","volume":"11","author":"Viale","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0007","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","article-title":"Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae","volume":"16","author":"Xu","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0008","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/cid\/ciw741","article-title":"Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia","volume":"64","author":"Tamma","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0009","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ajh.24489","article-title":"Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey","volume":"91","author":"Trecarichi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for Gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0011","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/jac\/dkaa397","article-title":"Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children","volume":"76","author":"Ara-Montojo","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.983174","article-title":"Carbapenem-resistant Enterobacteriaceae bloodstream infections: A case-control study from a pediatric referral hospital in Argentina","volume":"10","author":"Ruvinsky","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0013","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1097\/INF.0b013e3182804b49","article-title":"Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children","volume":"32","author":"Maltezou","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0014","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1097\/INF.0000000000001499","article-title":"Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India","volume":"36","author":"Nabarro","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0015","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/1469-0691.12085","article-title":"Predictive scoring model of mortality in Gram-negative bloodstream infection","volume":"19","author":"Al-Hasan","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0016","doi-asserted-by":"crossref","first-page":"ofy222","DOI":"10.1093\/ofid\/ofy222","article-title":"Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children","volume":"5","author":"Chiotos","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0017","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","article-title":"Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals","volume":"21","author":"Kadri","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0018","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-020-2742-9","article-title":"Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae","volume":"24","author":"Falcone","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0019","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bjid.2018.12.004","article-title":"Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection","volume":"23","author":"Liang","year":"2019","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0020","doi-asserted-by":"crossref","first-page":"ofz522","DOI":"10.1093\/ofid\/ofz522","article-title":"Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections","volume":"6","author":"Jorgensen","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0021","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13756-020-00728-3","article-title":"Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China","volume":"9","author":"Li","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.577244","article-title":"Clinical Observation and Prognostic Analysis of Patients With Klebsiella pneumoniae Bloodstream Infection","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04453-22","article-title":"Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital","author":"Zhang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0024","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.2147\/IDR.S374904","article-title":"Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections","volume":"15","author":"Meng","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11070616","article-title":"Risk Factors of 30-Day All-Cause Mortality in Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection","volume":"11","author":"Liu","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0026","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1128\/AAC.03007-15","article-title":"Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections","volume":"60","author":"Gomez-Simmonds","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0027","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1182\/blood-2008-01-130500","article-title":"Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists","volume":"112","author":"Wynn","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0028","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.cell.2018.06.045","article-title":"Stereotypic Immune System Development in Newborn Children","volume":"174","author":"Olin","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/270301","article-title":"Neonatal immune adaptation of the gut and its role during infections","volume":"2013","author":"Tourneur","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/jpids\/piz085","article-title":"Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children","volume":"9","author":"Chiotos","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0031","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1469-0691.2011.03553.x","article-title":"Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?","volume":"17","author":"Daikos","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0032","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0033","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4103\/ijmr.IJMR_760_19","article-title":"In vitro evaluation of antibiotic synergy for carbapenem-resistant Klebsiella pneumoniae clinical isolates","volume":"154","author":"Goel","year":"2021","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0034","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fcimb.2019.00422","article-title":"Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro","volume":"9","author":"Yu","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0035","doi-asserted-by":"crossref","first-page":"ofv050","DOI":"10.1093\/ofid\/ofv050","article-title":"Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections","volume":"2","author":"Morrill","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0036","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/14787210.2017.1318064","article-title":"Use of tigecycline in pediatric clinical practice","volume":"15","author":"Mastrolia","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0037","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/cid\/cis270","article-title":"Excess deaths associated with tigecycline after approval based on noninferiority trials","volume":"54","author":"Prasad","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0038","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/cid\/ciy492","article-title":"Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae","volume":"68","author":"Tumbarello","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0039","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/cid\/ciab176","article-title":"Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study","volume":"73","author":"Tumbarello","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0040","first-page":"61","article-title":"Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia","author":"Shields","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0041","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s40121-022-00682-0","article-title":"Ceftazidime\/Avibactam-Based Versus Polymyxin B-Based Therapeutic Regimens for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection in Critically Ill Patients: A Retrospective Cohort Study","volume":"11","author":"Zheng","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.780940","article-title":"Efficacy of Ceftazidime-Avibactam Versus Polymyxin B and Risk Factors Affecting Clinical Outcomes in Patients With Carbapenem-Resistant Klebsiella pneumoniae Infections a Retrospective Study","volume":"12","author":"Fang","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0043","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/cid\/ciaa061","article-title":"Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals","volume":"72","author":"Strich","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0044","article-title":"Neonatal Sepsis: The Impact of Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae","volume":"8","author":"Mukherjee","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0045","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1542\/peds.108.1.e12","article-title":"Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis","volume":"108","author":"Nupponen","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0046","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0140-6736(05)71048-5","article-title":"Lancet Neonatal Survival Steering T. 4 million neonatal deaths: when? Where? Why?","volume":"365","author":"Lawn","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0047","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.21037\/apm-21-338","article-title":"Predictors of mortality in patients with carbapenem-resistant Klebsiella pneumoniae infection: a meta-analysis and a systematic review","volume":"10","author":"Qian","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0048","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy","volume":"55","author":"Tumbarello","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0049","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.smim.2016.03.014","article-title":"Monocyte-mediated defense against bacteria, fungi, and parasites","volume":"27","author":"Lauvau","year":"2015","journal-title":"Semin Immunol"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0050","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1159\/000475665","article-title":"Monocyte Subsets Are Differentially Lost from the Circulation during Acute Inflammation Induced by Human Experimental Endotoxemia","volume":"9","author":"Tak","year":"2017","journal-title":"J Innate Immun"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0051","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3892\/etm.2021.10595","article-title":"Molecular mechanisms in septic shock (Review)","volume":"22","author":"Gorecki","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ijantimicag.2023.106933_bib0052","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12879-017-2297-9","article-title":"Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias","volume":"17","author":"Micozzi","year":"2017","journal-title":"BMC Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923002121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923002121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:46:54Z","timestamp":1760377614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923002121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0924857923002121"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106933","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae bacteraemia in children: a retrospective study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106933"}}